Dr. Erin Swinstead supports the firm's patent prosecution practice in the areas of biotechnology, molecular biology, genetics, and life science. Dr. Swinstead's research experience includes bioinformatics, cell biology, cancer biology, and high-throughput screening.
Before joining the firm, Dr. Swinstead completed a Post-Doctoral Fellowship at the National Cancer Institute/National Institutes of Health where she continued investigating the collaborative interactions of transcription factors in cancer. She was also a recipient of a Department of Defense Breast Cancer Breakthrough Fellowship Award.
Dr. Swinstead received her PhD in Cancer Biology through an affiliation between the University of Adelaide, Australia and the National Institutes of Health. Her graduate research utilized next generation sequencing coupled with computational methods to determine the dynamic interactions between steroid receptors and chromatin in breast cancer.
She has published in a number of peer-reviewed journals, including Cell.
- Postdoctoral Fellow, National Cancer Institute/National Institutes of Health, 2018
- PhD, Molecular Biology, University of Adelaide, 2014, Dean's Commendation
- Bachelor of Laboratory Medicine, Medical Science, University of South Australia, 2008
- *Not admitted to the practice of law